$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
地拉罗司纳入2021医保了吗?地拉罗司多少钱一盒?
2025-10-19 11:44:20
Check Details
祛铁药物地拉罗司,极大提高了患者生存质量和远期疗效
2025-10-19 11:44:20
Check Details
注意!地拉罗司,解救地中海贫血患者因频繁输血所致的慢性铁过载
2025-10-19 11:44:20
Check Details
地拉罗司分散片2021年纳入医保了吗?
2025-10-19 11:44:20
Check Details
地拉罗司分散片效果好不好
2025-10-19 11:44:20
Check Details
地拉罗司是什么药物?
2025-10-19 11:44:20
Check Details
地拉罗司2021年纳入医保了吗?
2025-10-19 11:44:20
Check Details
地拉罗司一般多久产生耐药?需要注意哪些?
2025-10-19 11:44:20
Check Details
地拉罗司需要空腹使用吗?使用时需要注意什么
2025-10-19 11:44:20
Check Details
地拉罗司Deferasirox作用机制是什么?有哪些注意事项
2025-10-19 11:44:20
Check Details
地拉罗司Deferasirox在河南能买到吗?多少钱一盒
2025-10-19 11:44:20
Check Details
地拉罗司的效果和副作用是什么?
2025-10-19 11:44:20
Check Details
1
2
...
48
49
50
51
52
53
54
...
937
938
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
2
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
3
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
4
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
5
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
6
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
7
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
8
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
9
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
10
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
11
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
12
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor